Measurements of HIV viral loads from different levels of the respiratory tract

Chest

Volumn 124, Issue 2, 2003, Pages 536-542

  Wood, Karen L ^a   Chaiyarit, Ponlatham ^a   Day, Richard B ^a   Wang, Yana ^a   Schnizlein Bick, Carol T ^a   Gregory, Richard L ^a   Twigg III, Homer L ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OPW 425 ^*  (United States)

Author keywords

BAL fluid; Bronchial fluid; HIV; Polymerase chain reaction; Saliva; Viral load

Indexed keywords

ADULT; ARTICLE; BRONCHUS SECRETION; CIGARETTE SMOKING; CLINICAL ARTICLE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVA LEVEL; TRACHEOBRONCHIAL TOILET; VIRUS DETECTION; VIRUS LOAD;

EID: 0042732918     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.124.2.536     Document Type: Article

References (38)

1. Wallace JM, Hansen NI, Lavange L, et al. Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort: Pulmonary Complications of HIV Infection study group. Am J Respir Crit Care Med 1997; 155:79-80
2. Mellors JW, Rinaldo CR Jr, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167-1170
3. Liuzzi G, Chirianni A, Clementi M, et al. Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS 1996; 10:F51-F56
4. Richman KM, Rickman LS. The potential for transmission of human immunodeficiency virus through human bites. J Acquir Immune Defic Syndr 1993; 6:402-406
5. Gooch B, Marianos D, Ciesielski C, et al. Lack of evidence for patient-to-patient transmission of HIV in a dental practiee. J Am Dent Assoc 1993; 124:38-44
6. Rogers MF, White CR, Sanders R, et al. Lack of transmission of human immunodeficiency virus from infected children to their household contacts. Pediatrics 1990; 85:210-214
7. Shugars DC, Slade GD, Patton LL, et al. Oral and systemic factors associated with increased levels of human immunodeficiency virus type 1 RNA in saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 89:432-440
8. Bourlet T, Cazorla C, Berthelot P, et al. Compartmentalization of HIV-1 according to antiretroviral therapy: viral loads are correlated in blood and semen but poorly in blood and saliva. AIDS 2001; 15:284-285
9. Lucht E, Albert J, Linde A, et al. Human immunodeficiency virus type 1 and cytomegalovirus in saliva. J Med Virol 1993; 39:156-162
10. Phillips J, Qureshi N, Barr C, et al. Low level of cell-free virus detected at high frequency in saliva from HIV-1-infected individuals. AIDS 1994; 8:1011-1012
11. Yeung SC, Kazazi F, Randle CG, et al. Patients infected with human immunodeficiency virus type 1 have low levels of virus in saliva even in the presence of periodontal disease. J Infect Dis 1993; 167:803-809
12. Liuzzi G, Bagnarelli P, Chirianni A, et al. Quantitation of HIV-1 genome copy number in semen and saliva. AIDS 1995; 9:651-653
13. Ho DD, Byington RE, Schooley RT, et al. Infrequency of isolation of HTLV-III virus from saliva in AIDS [letter]. N Engl J Med 1985; 313:1606
14. Shugars DC, Patton LL, Freel SA, et al. Hyper-excretion of human immunodeficiency virus type 1 RNA in saliva. J Dent Res 2001; 80:414-420
15. Moore BE, Flaitz CM, Coppenhaver DH, et al. HIV recovery from saliva before and after dental treatment: inhibitors may have critical role in viral inactivation. J Am Dent Assoc 1993; 124:67-74
16. McNeely TB, Dealy M, Dripps DJ, et al. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting antihuman immunodeficiency virus 1 activity in vitro. J Clin Invest 1995; 96:456-464
17. Archibald DW, Cole GA. In vitro inhibition of HIV-1 infectivity by human salivas. AIDS Res Hum Retroviruses 1990; 6:1425-1432
18. Coppenhaver DH, Sriyuktasuth-Woo P, Baron S, et al. Correlation of nonspecific antiviral activity with the ability to isolate infectious HIV-1 from saliva. N Engl J Med 1994; 330:1314-1315
19. Twigg HL, Soliman DM, Day RB, et al. Lymphocytic alveolitis, bronchoalveolar lavage viral load, and outcome in human immunodeficiency virus infection. Am J Respir Crit Care Med 1999; 159:1439-1444
20. Schaeffer ME, Rhodes M, Prince S, et al. A plastic intraoral device for the collection of human parotid saliva. J Dent Res 1977; 56:728-733
21. Shepard BN, Schock J, Robertson K, et al. Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments. J Clin Microbiol 2000; 38:1414-1418
22. Wahl SM, Worley P, Jin W, et al. Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues. Am J Pathol 1997; 150:1275-1284
23. Rennard SI, Basset G, Lecossier D, et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 1986; 60:532-538
24. Lewin SR, Kirihara J, Sonza S, et al. HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1-infected individuals. AIDS 1998; 12:719-727
25. Sierra-Madero JG, Toossi Z, Hom DL, et al. Relationship between load of virus in alveolar macrophages from human immunodeficiency virus type 1-infected persons, production of cytokines, and clinical status. J Infect Dis 1994; 169:18-27
26. Van Vyve T, Chanez P, Lacoste JY, et al. Comparison between bronchial and alveolar samples of bronchoalveolar lavage fluid in asthma. Chest 1992; 102:356-361
27. The BAL Cooperative Group Steering Committee. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis 1990; 141:S169-S202
28. Moja P, Jalil A, Quesnel A, et al. Humoral immune response within the lung in HIV-1 infection. Clin Exp Immunol 1997; 110:341-348
29. Cartry O, Moja P, Quesnel A, et al. Quantification of IgA and IgG and specificities of antibodies to viral proteins in parotid saliva at different stages of HIV-1 infection. Clin Exp Immunol 1997; 109:47-53
30. Nakata K, Rom WN, Honda Y, et al. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Respir Crit Care Med 1997; 155:996-1003
31. Koziel H, Kim S, Reardon C, et al. Enhanced in vivo human immunodeficiency virus-1 replication in the lungs of human immunodeficiency virus-infected persons with Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 1999; 160:2048-2055
32. Twigg HL III, Soliman DM, Spain BA. Impaired alveolar macrophage accessory cell function and reduced incidence of lymphocytic alveolitis in HIV-infected patents who smoke. AIDS 1994; 8:611-618
33. Wewers MD, Diaz PT, Wewers ME, et al. Cigarette smoking in HIV infection induces a suppressive inflammatory environment in the lung. Am J Respir Crit Care Med 1998; 158:1543-1549
34. Folks T, Kelly J, Benn S, et al. Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV. J Immunol 1986; 136:4049-4053
35. Laurence J, Hodtsev AS, Posnett DN. Superantigen implicated in dependence of HIV-1 replication in T cells on TCR V beta expression. Nature 1992; 358:255-259
36. Twigg HL III. Lung macrophage in human immunodeficiency viral infection. In: Russell SW, ed. Lung macrophages and dendritic cells in health and disease. New York, NY: Marcel Dekker, 1997; 571-610
37. Viscidi RP, Mayur K, Lederman HM, et al. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science 1989; 246:1606-1608
38. Iwamoto GK, Konicek SA, Twigg HL III. Modulation of accessory cell function and interleukin-6 production by the HIV-1 tat gene. Am J Respir Cell Mol Biol 1994; 10:580-585